8-K: CIMG Inc. Secures $1.07 Million Private Placement Amidst NASDAQ Non-Compliance and Delayed Filings

CIMG Inc. announced a private placement of 6 million common shares to non-U.S. investors for approximately $1.07 million, alongside a registration rights agreement, while disclosing ongoing non-compliance with NASDAQ listing rules and overdue financial reports.

Summary

• CIMG Inc. (Nasdaq: IMG) entered into a Share Purchase Agreement on June 2, 2025, for a private placement of 6,000,000 shares of common stock.
• The shares were sold to certain non-U.S. investors at a purchase price of $0.17808 per share, totaling an aggregate principal amount of $1,068,480.
• The transaction was conducted in reliance on Regulation S of the Securities Act of 1933, exempting it from U.S. registration requirements.
• The closing of the Share Purchase Agreement is expected to occur on or around June 9, 2025.
• Following the closing, CIMG Inc. expects to have a total of 36,397,418 shares of Common Stock issued and outstanding, up from 30,397,418 shares currently outstanding.
• In connection with the private placement, the Company also entered into a Registration Rights Agreement with the investors, committing to file a Form S-1 registration statement for the resale of these shares no later than August 8, 2025.
• The Company is obligated to keep the registration statement effective for continuous resales until all Registrable Securities are sold or can be sold without restriction under Rule 144.

Sentiment

Score: 2

Explanation: The capital raise itself provides liquidity, but the extremely low share price, significant dilution, and explicit disclosure of multiple ongoing NASDAQ listing non-compliance issues and delayed financial filings indicate severe underlying problems and a highly distressed situation for the company. These negatives heavily outweigh the positive of securing capital.

Positives

• The company successfully secured $1,068,480 in capital through a private placement, which can be used for general corporate purposes.
• The private placement was conducted with non-U.S. investors under Regulation S, which provides an exemption from U.S. securities registration requirements.
• The company entered into a Registration Rights Agreement, committing to facilitate the future resale of the shares by investors, which can make the investment more attractive to them.

Negatives

• The purchase price of $0.17808 per share is significantly lower than the typical trading price for Nasdaq-listed companies, potentially indicating a distressed valuation or substantial dilution for existing shareholders.
• The company explicitly disclosed existing non-compliance with NASDAQ Listing Rule 5550(b)(1) (Minimum Stockholders Equity Requirement).
• The company has failed to timely file its Form 10-K for fiscal year 2023 (ended September 30, 2024) and Form 10-Q for periods ended December 31, 2024, and March 31, 2025, indicating significant financial reporting deficiencies and potential delisting risk.
• The issuance of 6,000,000 new shares represents a substantial dilution of approximately 19.7% (6,000,000 / 30,397,418) to existing shareholders.

Risks

• NASDAQ Listing Non-Compliance: The company is not in compliance with NASDAQ Listing Rule 5550(b)(1) regarding the Minimum Stockholders Equity Requirement, which could lead to delisting.
• Untimely Financial Filings: Failure to timely file Form 10-K for FY2023 and Form 10-Q for Q1 and Q2 2025 indicates significant operational and compliance risks, potentially leading to further regulatory actions or delisting.
• Dilution: The issuance of 6,000,000 new shares will dilute the ownership percentage of existing shareholders by approximately 19.7%.
• Low Share Price: The private placement at $0.17808 per share suggests a very low valuation, which could reflect underlying business challenges or market perception.
• Restricted Securities: The shares are restricted securities under Rule 144, meaning investors cannot freely resell them until certain conditions are met or a registration statement becomes effective, which introduces liquidity risk for the new investors.

Future Outlook

The company is committed to filing a Form S-1 registration statement by August 8, 2025, to allow for the resale of the newly issued shares, and will maintain its effectiveness to facilitate continuous resales. The company also intends to maintain its listing on the Nasdaq Capital Market, despite current non-compliance issues.

Management Comments

• "CIMG Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized." (Signed by Jianshuang Wang, CEO)

Industry Context

This private placement indicates CIMG Inc.'s immediate need for capital, likely to support ongoing operations or strategic initiatives. The reliance on Regulation S for non-U.S. investors suggests a potential challenge in securing domestic financing or a strategic focus on international capital sources. The disclosed non-compliance with NASDAQ listing rules and delayed financial filings are significant red flags, placing the company in a precarious position compared to industry peers who typically maintain strict compliance for market access and investor confidence. Companies in similar situations often face increased scrutiny, higher cost of capital, and potential delisting, which can severely impact their ability to operate and grow.

Comparison to Industry Standards

• Capital Raising: While private placements are common, raising capital at $0.17808 per share for a Nasdaq-listed company is significantly below typical industry standards, often indicating severe financial distress or a 'penny stock' valuation. For example, established companies typically raise capital at prices well above $1.00 per share to maintain Nasdaq listing compliance.
• Financial Reporting Compliance: The failure to timely file Form 10-K and Form 10-Q for multiple periods is a severe deviation from industry standards. Publicly traded companies are expected to adhere strictly to SEC filing deadlines to ensure transparency and investor confidence. Peers like Apple (AAPL) or Microsoft (MSFT) consistently file on time, and even smaller, less established companies generally prioritize these filings to avoid regulatory penalties and delisting.
• Corporate Governance: The disclosed non-compliance with NASDAQ's Minimum Stockholders Equity Requirement (Rule 5550(b)(1)) is a critical governance issue. Most well-governed public companies actively manage their financials to remain compliant with exchange listing standards.
• Dilution: A nearly 20% dilution from a single capital raise, especially at such a low share price, is substantial and typically seen in highly distressed companies or early-stage ventures, not usually in established public companies without significant growth catalysts.

Corporate Governance

Stakeholder Impact

• Shareholders: Significant dilution (19.7%) due to the issuance of new shares at a very low price. Existing shareholders face potential loss of value and voting power.
• Investors (New): These non-U.S. investors are acquiring restricted securities at a low price, with the expectation of future liquidity via a registration statement. They bear the risk of the company's ongoing compliance issues and low valuation.
• Regulatory Bodies (SEC, NASDAQ): The company's non-compliance with filing deadlines and listing rules will likely lead to continued scrutiny and potential enforcement actions or delisting.
• Employees: While not directly mentioned, the company's financial distress and compliance issues could impact employee morale, retention, and future compensation.

Next Steps

• The closing of the Share Purchase Agreement is expected on or around June 9, 2025.
• CIMG Inc. is required to file a Form S-1 registration statement covering the resale of the 6,000,000 shares no later than August 8, 2025.
• The company must use commercially reasonable efforts to keep the registration statement effective for continuous resales until all Registrable Securities are sold or can be sold without restriction under Rule 144.
• The company needs to address its non-compliance with NASDAQ Listing Rule 5550(b)(1) and its overdue financial filings (Form 10-K for FY2023, Form 10-Q for Dec 2024, and Form 10-Q for March 2025) to avoid potential delisting.

Key Dates

Recommendation

Keywords

Private Placement, Equity Financing, Common Stock, Regulation S, SEC Filing, Form 8-K, Registration Rights Agreement, NASDAQ Listing Rules, Financial Reporting, Dilution, Capital Raise, CIMG Inc., IMG